Urethral Stricture Treatment Market

Urethral Stricture Treatment Market —Size, Share,
Outlook, and Opportunity Analysis, 2018 – 2026
Urethral stricture is a medical condition, which causes narrowing of the urethra due to presence
of a scar tissue, tissue inflammation, infection or injury. This condition can cause obstructive
dysfunction of urethra with potentially serious consequences for the entire urinary tract. The
urinary strictures are more common in males. They occur at any point along the urethra, but
are most often seen in the bulbar region and can range from less than 1cm long to the entire
length of the urethra. There are two types of urethral stricture conditions that occur in males,
which include posterior and anterior urethral strictures.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/2381
The cause of urethral stricture depends on the site of the stricture. Some of the common causes
for this condition are idiopathic, inflammatory (caused by infection or chronic inflammation in
urethra, e.g., lichen sclerosus), traumatic (caused due to injury to the urethra), iatrogenic
(caused by medical intervention such as endoscopic procedures, urethral catheterization,
radiotherapy or surgery to neighboring organs), and congenital (caused by inherited conditions
such as hypospadias and epispadias).
Some of the common symptoms of urethral strictures includes painful urination, reduced urine
output, incomplete emptying of the bladder, and inability to void. There are various types of
treatment available for urethral strictures ranging from conservative or minimally invasive
procedures to complex reconstructive procedures such as direct vision internal urethrotomy
(DVIU), urethroplasty, urethral dilation, and others.
Report includes chapters which deeply display the following deliverable about industry :
• Urethral Stricture Treatment Market Research Objective and Assumption
• Urethral Stricture Treatment Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Urethral Stricture Treatment Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Urethral Stricture Treatment Market, By Regions
• Urethral Stricture Treatment Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Urethral Stricture Treatment Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Urethral Stricture Treatment Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Urethral Stricture Treatment Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Urethral Stricture Treatment Market - Market Dynamics
Increasing cases of prostate cancers, injuries, and medical conditions requiring urethral stents,
dilators, and catheters is one of the major factors for rise in urethral stricture cases, which in
turn is driving growth of the urethral stricture treatment market.
According to the National Centers for Biotechnology & Information (NCBI), urethral stricture is
a common disease with prevalence of over 400 per 100,000 population among males in year
2016 globally. According to the Cancer Research UK, in males in the U.K., prostate cancer is
the most common cancer with around 47,200 new cases registered in 2015. Moreover, the
incidence rates of prostate cancer are projected to rise by 12% between 2014 and 2035, to 233
cases per 100,000 males by 2035 in the U.K., as per Cancer Research UK. High catheter
associated urinary tract infection (CAUTI) rates of 6.8 per 1000 device days were observed in
the UAE medical units in March 2015.
Moreover, advancements in development of therapies for treating urethral strictures is driving
growth of the urethral stricture treatment market. For instance, a Germany-based company,
MukoCell GmbH developed a tissue engineering-based product called MukoCell, which is used
for repair of urethral strictures and hypospadias. This product is an alternative to conventional
transplantation with native buccal mucosa.
However, high cost of surgical procedures and high rate of complications are some of the major
factors restraining growth of the global urethral stricture treatment market. According to
Healthcare Cost and Utilization Project (HCUP) 2016, the average cost of male urethroplasty can
range between US$ 5,677–US$ 10,000 with an average increase of US$ 616 per year in the U.S.
Urethral Stricture Treatment Market – Regional Insights
On the basis of geography, the global urethral stricture treatment market is segmented into
North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America
held dominant position in the global urethral stricture treatment market in 2017. This is owing
to rising number of urethroplasties for urethral strictures in the region. Moreover, high adoption
rate of innovative technologies and numerous product development is driving growth of the
market. For instance, in February 2018, Urotronic, an early stage medical device company,
received license for its product, Optilume drug-coated balloon (DCB), which will be used to
treat urethral strictures in Canada. The development of this drug-coated ballon have a
significant impact across Canada due to scarcity of physicians currently to perform majority of
urethral stricture treatments.
Asia Pacific is expected to witness significant growth in the urethral stricture treatment market
during the forecast period, owing to improving health care infrastructure in economies such as
India and China, and increasing demand for efficient treatment options for urethral strictures.
Urethral Stricture Treatment Market – Competitive Landscape
Major players operating in the global urethral stricture treatment market include C. R. Bard,
Inc., Amecath, Uromed, MedNova, Allium Medical, Surgimedik, Cook Medical Inc., Mednova,
Taewoong Medical, Teleflex Incorporated, B. Braun Holding GmbH & Co. KG, Urotech,
Coloplast Ltd, Boston Scientific Corporation, and Pnn Medical A/S. Key players are focusing on
expanding their product portfolio, in order to retain dominant position in the market. For
instance, Allium Medical, which manufactures and markets minimally invasive products, entered
into the market with its product, Allium’s Ureteral Stents, which has some unique composition
and better bio-compatibility.
Browse Complete Report For More Information @ http://bit.ly/2IOM4FA
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Urethral stricture is a medical condition, which causes narrowing of the urethra due to presence of a scar tissue, tissue inflammation, infection or injury.

Download Report